These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9394096)
1. Testosterone suppression of the HPT axis. MacIndoe JH; Perry PJ; Yates WR; Holman TL; Ellingrod VL; Scott SD J Investig Med; 1997 Oct; 45(8):441-7. PubMed ID: 9394096 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. Safarinejad MR J Neuroendocrinol; 2008 Dec; 20(12):1368-75. PubMed ID: 19094084 [TBL] [Abstract][Full Text] [Related]
3. Effect of nitric oxide synthase inhibitors on preventing ethanol-induced suppression of the hypothalamic-pituitary-gonadal axis in the male rat. Shi Q; Emanuele NV; Emanuele MA Alcohol Clin Exp Res; 1998 Nov; 22(8):1763-70. PubMed ID: 9835292 [TBL] [Abstract][Full Text] [Related]
4. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464 [TBL] [Abstract][Full Text] [Related]
5. Predictors for partial suppression of spermatogenesis of hormonal male contraception. Li JW; Gu YQ Asian J Androl; 2008 Sep; 10(5):723-30. PubMed ID: 18645675 [TBL] [Abstract][Full Text] [Related]
6. Effects of an organophosphate pesticide, quinalphos, on the hypothalamo-pituitary-gonadal axis in adult male rats. Sarkar R; Mohanakumar KP; Chowdhury M J Reprod Fertil; 2000 Jan; 118(1):29-38. PubMed ID: 10793623 [TBL] [Abstract][Full Text] [Related]
7. Hormonal contraception in Chinese men: variations in suppression of spermatogenesis with injectable testosterone undecanoate and levonorgestrel implants. Liu ST; Gui YL; Lin CH; He CH Asian J Androl; 2004 Mar; 6(1):41-6. PubMed ID: 15064833 [TBL] [Abstract][Full Text] [Related]
8. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study. Erb K; Pechstein B; Schueler A; Engel J; Hermann R Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648 [TBL] [Abstract][Full Text] [Related]
9. Effects of an LHRH agonist analog upon sexual function in male dogs. Suppression, reversibility, and effect of testosterone replacement. Vickery BH; McRae GI; Briones W; Worden A; Seidenberg R; Schanbacher BD; Falvo R J Androl; 1984; 5(1):28-42. PubMed ID: 6231277 [TBL] [Abstract][Full Text] [Related]
10. Biphasic effect of testosterone on spermatogenesis in the rat. Walsh PC; Swerdloff RS Invest Urol; 1973 Nov; 11(3):190-3. PubMed ID: 4749418 [TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide treatment causes impairment of sperm and its fertilizing ability in mice. Elangovan N; Chiou TJ; Tzeng WF; Chu ST Toxicology; 2006 May; 222(1-2):60-70. PubMed ID: 16517039 [TBL] [Abstract][Full Text] [Related]
12. Adult exposure to bisphenol A (BPA) in Wistar rats reduces sperm quality with disruption of the hypothalamic-pituitary-testicular axis. Wisniewski P; Romano RM; Kizys MM; Oliveira KC; Kasamatsu T; Giannocco G; Chiamolera MI; Dias-da-Silva MR; Romano MA Toxicology; 2015 Mar; 329():1-9. PubMed ID: 25575453 [TBL] [Abstract][Full Text] [Related]
13. Combined effects of androgen anabolic steroids and physical activity on the hypothalamic-pituitary-gonadal axis. Hengevoss J; Piechotta M; Müller D; Hanft F; Parr MK; Schänzer W; Diel P J Steroid Biochem Mol Biol; 2015 Jun; 150():86-96. PubMed ID: 25797375 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of the gonadotoxicity of Cytoxan in the dog by adjuvant treatment with a luteinizing hormone-releasing hormone agonist. Goodpasture JC; Bergstrom K; Vickery BH Cancer Res; 1988 Apr; 48(8):2174-8. PubMed ID: 2964898 [TBL] [Abstract][Full Text] [Related]
16. The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia. Farmakiotis D; Farmakis C; Rousso D; Kourtis A; Katsikis I; Panidis D Fertil Steril; 2007 Oct; 88(4):847-53. PubMed ID: 17412336 [TBL] [Abstract][Full Text] [Related]
17. Suppression of growth hormone does not affect ongoing spermatogenesis in rats. Awoniyi CA; Veeramachaneni DN; Roberts D; Tucker KE; Chandrashekar V; Schlaff WD J Androl; 1999; 20(1):102-8. PubMed ID: 10100480 [TBL] [Abstract][Full Text] [Related]
18. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone. Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide impairs spermatogenesis via reducing gene expression levels in testosterone synthesis pathway. Chiou TJ; Chu ST; Tzeng WF; Huang YC; Liao CJ Chem Res Toxicol; 2008 Aug; 21(8):1562-9. PubMed ID: 18630931 [TBL] [Abstract][Full Text] [Related]
20. Treatment of young rams with an agonist of GnRH delays reproductive development. Tilbrook AJ; Galloway DB; Williams AH; Clarke IJ Horm Behav; 1993 Mar; 27(1):5-28. PubMed ID: 8440517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]